JSH-009 | Interleukin Related interleukin-related.com

Product Name :
JSH-009

Search keywords :
JSH-009

drugId :
null

Target Vo:
Cyclin-dependent kinase 9

Target Vo Short Name :
CDK9

Moa_Name:
Cyclin-dependent kinase 9 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Hefei Academy Of Physical Sciences, Chinese Academy Of Sciences

Active Company_Name :
Hefei Academy Of Physical Sciences, Chinese Academy Of Sciences

Active Indication_Name:
Leukemia, Myeloid, Acute

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-Aurora A Antibody
C/EBP Beta Antibody
BrdU Antibody (YA578): BrdU Antibody (YA578) is a non-conjugated and Rabbit origined monoclonal antibody, targeting to BrdU. It can be used for IHC-P,ICC/IF,FC assays with tag free, in the background of .

Author: Interleukin Related

Related Posts